Skip to content

AXSOME THERAPEUTICS, INC.

AXSM

CIK 0001579428

← back to feed
Revenue (TTM)
$633.7M
+65.5% YoY Q1 Apr 2026
Net Income (TTM)
−$219.16M
+36.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$4.39
+38.6% YoY Q1 Apr 2026
Gross Margin
99.2%
Q1 Apr 2026
Operating Margin
-32.1%
Q1 Apr 2026
Net Margin
-34.6%
Q1 Apr 2026
Free Cash Flow (TTM)
−$123.99M
Q1 Apr 2026
Cash
$305.11M
Q1 Apr 2026
Total Debt
$187.85M
Q1 Apr 2026
Shares Outstanding
51.46M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings